Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Author: Avi Kapoor | October 02, 2024 07:21am

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Wednesday.

Shares of NIKE, Inc (NYSE:NKE) fell sharply in today's pre-market trading following first-quarter results.

The company reported first-quarter revenue of $11.59 billion, missing analyst estimates of $11.65 billion. The athletic footwear and apparel company reported first-quarter earnings of 70 cents per share, beating analyst estimates of 52 cents per share.

NIKE shares declined 5.5% to $84.25 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

  • Humana Inc. (NYSE:HUM) shares declined 24% to $212.77 in pre-market trading after the company provided update on decline in Stars performance for 2025 and how it will impact quality bonus payments in 2026.
  • TC Energy Corporation (NYSE:TRP) dipped 7.1% to $44.94 in pre-market trading. TC Energy provided conversion right and dividend rate notice for Series 9 and 10 preferred shares.
  • Alignment Healthcare, Inc. (NASDAQ:ALHC) shares fell 6.9% to $9.31 in pre-market trading after dipping over 15% on Tuesday.
  • Bausch + Lomb Corporation (NYSE:BLCO) shares declined 6% to $18.00 in pre-market trading.
  • Lamb Weston Holdings, Inc. (NYSE:LW) shares fell 4.5% to $62.00 in pre-market trading. The company reported better-than-expected earnings for its third quarter and announced plans to cut approximately 4% of the global workforce and eliminate unfilled job positions.
  • Lilium N.V. (NASDAQ:LILM) shares declined 4.4% to $0.7290 in pre-market trading.
  • Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares fell 3.4% to $14.50 in pre-market trading.

Now Read This:

Posted In: ALHC BLCO CAPR HUM LILM LW NKE TRP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist